Theodore G. Clark
Gründer bei AbCellera Boston, Inc.
Profil
Theodore G.
Clark is the founder of AbCellera Boston, Inc., which was founded in 2004.
He holds the title of Director & Chief Scientific Officer at AbCellera Boston, Inc. from 2010 to the present.
Dr. Clark is currently working as the Director-Graduate Program at Cornell University.
He has previously worked at Yale University as a Member and at the University of Georgia as a Principal.
Dr. Clark has an undergraduate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from Stony Brook University.
Aktive Positionen von Theodore G. Clark
Unternehmen | Position | Beginn |
---|---|---|
AbCellera Boston, Inc.
AbCellera Boston, Inc. BiotechnologyHealth Technology AbCellera Boston, Inc. produces vaccines for plant, animal, and human diseases. It focuses on the discovery of novel therapeutics for autoimmune disease and pain. The company was founded by Theodore G. Clark in 2004 and is headquartered in Arlington, MA. | Gründer | 01.01.2004 |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Theodore G. Clark
Unternehmen | Position | Ende |
---|---|---|
University of Georgia | Corporate Officer/Principal | - |
Yale University | Corporate Officer/Principal | - |
Ausbildung von Theodore G. Clark
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Stony Brook University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
AbCellera Boston, Inc.
AbCellera Boston, Inc. BiotechnologyHealth Technology AbCellera Boston, Inc. produces vaccines for plant, animal, and human diseases. It focuses on the discovery of novel therapeutics for autoimmune disease and pain. The company was founded by Theodore G. Clark in 2004 and is headquartered in Arlington, MA. | Health Technology |